SCHEMBL9533573

SCHEMBL9533573

COc1cc(/C=C/C(=O)CCc2ccco2)ccc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 8/20 0.70
▸ MAPT P10636 7/20 0.70
▸ BACE1 P56817 4/20 0.64
▸ ALOX5 P09917 4/20 0.64
▸ NFKB1 P19838 4/20 0.64
▸ CYP2D6 P10635 3/20 0.64
▸ STAT3 P40763 3/20 0.64
▸ NFKB2 Q00653 3/20 0.64
▸ RELA Q04206 3/20 0.64
▸ MMP9 P14780 3/20 0.64
▸ CYP2C9 P11712 2/20 0.64
▸ TSHR P16473 2/20 0.64
▸ HSD17B10 Q99714 2/20 0.64
▸ ABCB1 P08183 2/20 0.64
▸ AKR1B1 P15121 2/20 0.64
▸ MAOA P21397 2/20 0.64
▸ MAOB P27338 2/20 0.64
▸ HDAC3 O15379 2/20 0.64
▸ HDAC1 Q13547 2/20 0.64
▸ HDAC2 Q92769 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9533579 1.00 APP (0.70) APPMAPTBACE1ALOX5NFKB1
SCHEMBL9535664 0.89 ALOX5 (0.67) APPMAPTBACE1ALOX5NFKB1
SCHEMBL10538423 0.89 ALOX5 (0.67) APPMAPTBACE1ALOX5NFKB1
SCHEMBL9533984 0.85 CAPN1 (0.55) APPMAPTBACE1ALOX5NFKB1
SCHEMBL9533980 0.85 CAPN1 (0.55) APPMAPTBACE1ALOX5NFKB1
SCHEMBL9579738 0.84 ALOX5 (0.57) APPMAPTBACE1ALOX5NFKB1
SCHEMBL9579740 0.84 ALOX5 (0.57) APPMAPTBACE1ALOX5NFKB1
SCHEMBL9579827 0.84 ALOX5 (0.57) APPMAPTBACE1ALOX5NFKB1
SCHEMBL3220811 0.82 APP (1.00) APPMAPTBACE1ALOX5NFKB1
SCHEMBL3220795 0.82 APP (1.00) APPMAPTBACE1ALOX5NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4810716-A ANTIINFLAMMATORY, ANTIALLERGY, ANTIISCHEMIC WARNER-LAMBERT COMPANY (US) 1989-03-07 — — US claimed
EP-0241043-A2 Novel diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1987-10-14 — — EP claimed
EP-0241043-B1 NOVEL DIARYLALKANOIDS HAVING ACTIVITY AS LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1993-09-01 — — EP disclosed
US-5177259-A Diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1993-01-05 — — US disclosed
US-5142095-A Treating inflammation, allergies, asthma, cardiovascular disorders, psoriasis WARNER-LAMBERT COMPANY (US) 1992-08-25 — — US disclosed
US-5077411-A Antiallergens, antiinflammatory agents; cardiovascular disorders, migraines, psoriasis WARNER-LAMBERT CO. (US) 1991-12-31 — — US disclosed
US-4959503-A Diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1990-09-25 — — US disclosed
US-4810716-A ANTIINFLAMMATORY, ANTIALLERGY, ANTIISCHEMIC WARNER-LAMBERT COMPANY (US) 1989-03-07 — — US disclosed
EP-0241043-A2 Novel diarylalkanoids having activity as lipoxygenase inhibitors WARNER-LAMBERT COMPANY (US) 1987-10-14 — — EP disclosed
Send feedback